statistics

You have access
Cost-effectiveness of ¹⁸F-FET PET for early treatment response assessment in glioma patients following adjuvant temozolomide chemotherapy
Jurij Rosen, Garry Ceccon, Elena Katharina Bauer, Jan Michael Werner, Caroline Tscherpel, Veronika Dunkl, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Alexander Heinzel, Niklas Schaefer, Maximilian Ruge, Roland Goldbrunner, Gabriele Stoffels, Christoph Kabbasch, Gereon Rudolf Fink, Karl-Josef Langen and Norbert Galldiks

Journal of Nuclear Medicine April 14, 2022, jnumed.122.263790; DOI: https://doi.org/10.2967/jnumed.122.263790
You have access
Nuclear Medicine and Artificial Intelligence: Best Practices for Algorithm Development
Tyler J. Bradshaw, Ronald Boellaard, Joyita Dutta, Abhinav K. Jha, Paul Jacobs, Quanzheng Li, Chi Liu, Arkadiusz Sitek, Babak Saboury, Peter J.H. Scott, Piotr J. Slomka, John J. Sunderland, Richard L. Wahl, Fereshteh Yousefirizi, Sven Zuehlsdorff, Arman Rahmim and Irène Buvat

Journal of Nuclear Medicine April 1, 2022, 63 (4) 500-510; DOI: https://doi.org/10.2967/jnumed.121.262567
You have access
Statistical Considerations in the Evaluation of Continuous Biomarkers
Mei-Yin C. Polley and James J. Dignam

Journal of Nuclear Medicine May 10, 2021, 62 (5) 605-611; DOI: https://doi.org/10.2967/jnumed.120.251520
You have access
Prognostic Value of Total Lesion Glycolysis by ¹⁸F-FDG PET/CT in Surgically Resected Stage IA Non–Small Cell Lung Cancer
Seong Yong Park, Arthur Cho, Woo Sik Yu, Chang Young Lee, Jin Gu Lee, Dae Joon Kim and Kyung Young Chung

Journal of Nuclear Medicine January 1, 2015, 56 (1) 45-49; DOI: https://doi.org/10.2967/jnumed.114.147561

Main menu

User menu

Search

statistics